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Objectives: autologous arterio-venous (AV) fistulas seem to be superior to prothetic grafts in hemodialysis access surgery.
We used an algorithm which enabled us to use autologous vein in over 99% of all fistula operations.
Design: all patients undergoing hemodialysis surgery during a three year period (n 102) were enrolled in an open
prospective observation study with the end points feasibility, perioperative complications and patency.
Materials: one hundred and two patients were followed until the end of the observation period (30/6/01).
Methods: all relevant data were recorded prospectively. The status of the individual fistula was recorded twice a year until
the end of the observation period. Fistula-patency was calculated by life-table-analysis according to Kaplan±Meier.
Results: except one patient presenting with a recurrent shunt aneurysm, no patient received prothetic material. At the end
of the observation period all patients alive and under dialysis could use their autologous fistula. There was no perioperative
mortality. One reoperation was required for a septic anastomotic rupture. Otherwise, only minor complications were
observed. Cumulative 1-year and 3-year patency were 78.5 and 62.8% respectively for the Cimino and 75.2 and 66.8% for
elbow fistulas.
Conclusions: an autologous approach is nearly always possible. Besides fewer complications, the approach seems to be cost
effective.
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Introduction
The number of patients requiring hemodialysis for
renal insufficiency is steadily increasing in Western
countries. With the increase in life-expectancy, a con-
tinuation of this trend can be anticipated. In the mid-
nineties approximately 100 000 hemodialysis access
procedures were performed in the U.S.A. per year.
The best way to provide hemodialysis access is still a
matter of debate, however.1 During the last decade
there has been a trend towards creating autogenous
arteriovenous fistulas more often.1±4
Nevertheless a considerable number of vascular
surgeons are still in favour of PTFE grafts for various
reasons. In spite of admitting that the primary patency
rate of PTFE grafts is significantly lower than with
arteriovenous fistulas, they argue that secondary
patency rates for both procedures are similar and,
moreover, autogenous fistulas have a tendency
towards failing to mature, and can not be created
due to technical problems related to the patients vas-
cular status in a considerable number of cases.5±7
We developed an algorithm which enabled us to
create an autologous fistula in every patient trans-
ferred to our institution for hemodialysis access. The
approach was associated with a low incidence of peri-
operative and long-term complications. Additionally,
we calculated that there is a significant reduction of
the cost of hemodialysis access procedures by mini-
mizing the use of PTFE grafts and reducing the need
for secondary procedures.
Materials and Methods
One hundred and two patients were admitted for
hemodialysis access surgery between 1/1/98 and
31/12/2000. Their relevant preoperative data were
recorded prospectively. Most of the patients were
transferred by an affiliated hemodialysis unit for the
creation of primary hemodialysis access or restoration
of flow in the case of compromised access function.
Taking into account the high infection rate after
implantation of PTFE-protheses for hemodialysis, we
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decided to institutionalize an algorithm completely
relying on autologous procedures (Fig. 1). A Cimino-
fistula in the non-dominant arm was the first choice,
an elbow-fistula using the cephalic vein the second. If
the shunt matured within four weeks but was difficult
to puncture, the shunt-vein was dissected free and
transposed directly underneath the skin (Transpos-
ition). All operations were performed by a single sur-
geon using magnifying lenses. Cimino and elbow
fistulas were created in an end-to-side-fashion using
6-0 or 7-0 monofilament absorbable sutures. Eighty
percent of the operations were performed under
local or regional anaesthesia.
Every patient was investigated clinically with a
tourniquet before the operation. Every patient under-
going a redo procedure and patients with poor venous
status underwent duplex ultrasound. Patients with
primary transposition underwent a phlebography.
For a DRIL procedure we examined the patients by
arteriography and functional Duplex-ultrasound.
After the operation, fistula patency was assessed
twice a day for the first two postoperative days. Hemo-
dialysis usually commenced during the third week
after the operation. In special cases, mostly when
deciding on an alternative temporary access via a
Sheldon catheter, the autologous fistula was used
earlier after discussion between us and the hemodia-
lysis unit.
The status of the individual fistula was recorded
twice a year by a standard questionaire completed
by the hemodialysis unit. The observation period
ended 30/6/01. Follow-up was complete because all
operated patients underwent hemodialysis at only
two centers. Fistula-patency was calculated by life-
table-analysis according to Kaplan±Meier.
Results
During a 3-year-period 102 patients underwent 140
hemodialysis access-procedures in our department.
Sixty were male and 42 female (m:f ratio 1.4:1).
Their mean age was 62.8 (median 61.5) years and
30.4% had insulin-dependent diabetes.
Fifty-two patients were transferred for creation of a
primary fistula (51.0%), while in 41 patients a new
fistula had to be constructed after occlusion of the
old fistula/graft (Table 1). Fifteen patients (14.7%)
had undergone two or more hemodialysis access pro-
cedures at other hospitals, including one patient who
had had seven failed attempts to create hemodialysis
access (including PTFE grafts at the forearm and a
femorosaphenal PTFE graft). He is now under con-
tinuous hemodialysis 29 months after construction of
an elbow fistula (median basilic vein to brachial
artery) and consecutive transposition.
In all but one patient the implantation of protheses
could be avoided. Altogether 48 Cimino and forearm
fistulas, 56 elbow fistulas and 3 primary basilic vein
transpositious were performed (Table 1). Among
patients with a patent fistula but puncture problems
of the shunt vein, 19 transpositions were performed
(four at the forearm and 15 at the upper arm). In all
patients who were transferred after multiple failed
attempts to establish access at other hospitals, creation
of an autologous fistula was successful.
In our series the perioperative mortality was 0%. A
septic anastomotic rupture requiring immediate opera-
tive intervention was the most serious complication we
observed. Additionally we observed four hematomas,
Fig. 1. Algorithm for the selection of an individual autogenous
hemodialysis access procedure.
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theoperated arm, none ofwhichneededoperative inter-
vention (Reoperation rate 1/140: 0.7%; perioperative
complications 9/140: 6.4%).
During the observation period ending 30/06/01
(median observation time: 18 months) we observed
35 shunt occlusions. No patient was lost to follow-
up. Four patients died due to causes not related to
the operation during follow-up. Three functioning fis-
tulas were not used for hemodialysis because renal
insufficiency improved after construction of the shunt.
The cumulative 1-year primary patency rate for all
shunt-operations was 73.6% and the cumulative 3-
year patency was 64.0%. Except for the one patient
receiving an artificial graft as a secondary procedure
all patients alive and requiring hemodialysis have a
functioning autologous fistula. The 1-year primary
patency rate for primary Cimino fistulas was 78.5%
in our series, the 3-year primary patency rate 62.8%,
and the secondary patency rate 64.8% (Table 2). For
elbow fistulas we observed a 1-year primary patency
rate of 75.2% and a 3-year patency rate of 66.8%.
Transposition operations in patients with a function-
ing A.V. fistula were all succesful, with no perioperative
complications.
An interesting subgroup comprised six patients, all
diabetic, with a steal phenomenon after construction
of an elbow fistula. By a DRIL-procedure (Distal
Revascularization Interval Ligation) it was possible
in all of them to preserve the functioning access and
treat ischemia of the hand and fingers succesfully.
Discussion
Although it is well known that patients suffering from
renal insufficiency are susceptible to infection PTFE
protheses have been widely used in hemodialysis
access surgery.6±9 It is not surprising that high rates
of early and late infection in such protheses are
reported in the literature, ranging between 5 and
20%. During the last few years surgeons involved
with hemodialysis access surgery have become more
and more aware of the fact that autologous fistulas are
superior to artificial grafts in terms of perioperative
complications and patency.1,10±12 However, some
experienced vascular surgeons in the U.S.A. consider
only half of the patient eligible for construction of an
autologous A.V. fistula.1±3
Having experienced very severe, occasionally even
fatal, complications of prothetic grafts for hemodialy-
sis access, we decided to institute an algorithm using
autologous fistulas/procedures whenever possible
(Fig. 1). Our results concerning perioperative compli-
cations and patency are in the upper range of com-
parable reports.2,7,10 However, in our series we have
shown that an autologous approach is feasible in
every patient referred to us with a hemodialysis access
problem. (We considered it prudent to implant a
protheses in only one patient, who developed a recur-
rence 18 months after resection and autologous recon-
struction of a shunt aneurysm.)
In addition the autologous approach seems to be the
more cost effective.1 The costs of the protheses is not
offset by the longer operating time or in-hospital-stay
when autologous vein is used. Additionally, fewer
procedures are needed to maintain patency than in
prothetic grafts, which tend to occlude more often
and sometimes require multiple thrombectomies.5±8
Even if the steal phenomenon presents a serious
threat to fistula patency and the extremity, this can
be remedied by an autologous procedure.13 Like
Berman et al. have pointed out in their landmark
article on the procedure reporting the results on
21 patients, we have lost neither a graft nor a digit in
patients suffering from a steal phenomenon.13
What is crucial for the success of the autologous
approach? It needs vascular surgeons who are familiar
with microsurgical techniques (a fistula should
never be constructed without magnifying lenses) and
committed to overcoming the various problems of
Table 1. Patients and procedures.
Primary Secondary Tertiary
and higher
A.V. Fistulas
Dist. cimino 32 3 ±
Forearm 4 6 3
Elbow 16 26 14
Primary transposition ± ± 3
Transposition
Cimino 3 1 ±
Elbow 2 7 6
DRIL Procedure
Forearm 1 ± ±
Elbow 2 2 1
Miscellaneous
Shunt aneurysm 2 2 ±
Revision of shunt stenosis 4 7 3
Table 2. Patency rates of autologous a.v. fistulas.
Patency rate at 1-year
(patients at risk)
3-years
(patients at risk)
Cimino primary  (n 36) 79% (27) 63% (14)
Elbow primary (n 16) 69% (11) 60% (8)
Elbow sec. and higher (n 40) 83% (29) 72% (16)
Not calculated due to low number of patients at risk, including
forearm fistulas.
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hemodialysis access surgery. Most problems can be
solved using atraumatic techniques and standard pro-
cedures like Cimino- and elbow fistulas. After a failed
elbow fistula, basilic vein transposition can offer the
patient many more years of fistula use without the
intrinsic problems of a prothetic graft.11 In the case of
a functioning mature fistula that is difficult to punc-
ture, shunt vein transposition usually guarantees con-
tented patient and dialysis physician.
For cases transferred with several non-functioning
PTFE-grafts in their arms and sometimes even their
thighs, we endorse the advice of Nicholson who has
pointed out: `` remember the basilic vein''.14
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